Theme: “Diagnosis: First step to care”
On World Hemophilia Day 2026, under the theme “Diagnosis: First step to care,” we are reminded that for many, life with Hemophilia begins not with treatment, but with years of uncertainty—unexplained bleeding, recurring pain, and countless hospital visits without answers. In under-resourced settings, this silence around diagnosis often drives families into cycles of frustration, financial strain, and even reliance on ineffective traditional remedies, deepening both emotional and economic burdens. Hemophilia, a condition where the blood lacks the ability to clot properly, can be managed with timely diagnosis through regular factor replacement therapy, proper nutrition, and injury prevention; yet without that crucial first step, much is lost—missed school days, limited opportunities, chronic joint damage, and preventable lifelong disability. Bridging the gap between symptoms and diagnosis is not just a medical necessity; it is the difference between a life defined by struggle and one sustained with dignity and care.
About World Hemophilia Day
World Hemophilia Day, led by the World Federation of Hemophilia, is observed every year on April 17 to raise awareness of hemophilia and other inherited bleeding disorders, and to advocate for improved access to care worldwide. Established in 1989, the day brings together patients, caregivers, clinicians, and policymakers in a shared call to improve diagnosis, treatment and quality of life for affected individuals.
In 2026, the theme “Diagnosis: First step to care” highlights a critical global gap: millions of people living with bleeding disorders remain undiagnosed, with estimates suggesting that more than three-quarters of individuals with hemophilia worldwide have not been identified. Diagnosis is therefore framed as the most essential entry point into care. Without it, patients cannot access lifesaving treatments, appropriate management, or even basic awareness of their condition. Early and accurate diagnosis not only prevents avoidable complications and deaths but also opens the door to comprehensive care, including education and support systems.
For 2026, the global community is calling for strengthened screening systems, improved laboratory capacity, and greater awareness among healthcare providers and the public to close the diagnosis gap. The emphasis is on ensuring that every person with a bleeding disorder, regardless of geography, gender, or socioeconomic status, is identified early and linked to care, advancing the broader vision of “treatment for all.”
Digital Health and Data Enabling Diagnosis
Digital health is a powerful enabler of the kind of systematic, data-driven diagnosis envisioned by the World Federation of Hemophilia under the 2026 theme. Through digitizing health records, integrating laboratory systems and enabling real-time data sharing, digital platforms help shift diagnosis from being reactive and fragmented to proactive and coordinated.
First, digital health systems improve the visibility of rare and chronic conditions like Hemophilia. Because hemophilia is often underreported and misdiagnosed, centralized electronic health records and national registries make it easier to identify patterns such as recurrent unexplained bleeding across populations. This data aggregation helps health systems identify cases that might otherwise go unnoticed, especially in underserved regions.
Second, structured data collection plays a critical role in earlier detection and referral. When clinicians consistently capture standardized information (bleeding history, family history, and lab results) digital systems can flag high-risk patients for further investigation. Automated alerts and clinical decision-support tools can prompt timely referrals to specialists, reducing delays that often span years, as seen in many late diagnoses.
Third, digital health connects the dots across a patient’s journey– primary care visits, laboratory testing, specialist consultations and ongoing treatment. Interoperable systems ensure that patient information flows seamlessly. This continuity of care is especially important for chronic conditions, where fragmented records can lead to missed diagnoses, duplicated tests, or suboptimal treatment. Telemedicine and mobile health tools further extend this connectivity, enabling patients in remote areas to access expertise without geographic barriers.
Currently, very few health facilities are adequately equipped to diagnose and manage hemophilia, and awareness of the condition remains low across many communities. There is an urgent need to both expand the number of specialized treatment centers and strengthen the capacity of existing facilities. At the same time, sustained public and healthcare worker awareness campaigns are essential to promote early recognition of symptoms. For instance, in Kenya, only a few facilities currently provide comprehensive diagnostic services and dedicated care for hemophilia patients, highlighting a significant access gap that must be addressed. Through the Kenya Haemophilia Association and its partners, key centers accessible to the average Kenyan include Kenyatta National Hospital (Nairobi), Moi Teaching and Referral Hospital (Eldoret), Coast General Teaching and Referral Hospital (Mombasa), and Murang’a County Referral Hospital.
To move forward, a combined approach is needed: investment in digital health infrastructure, expansion of diagnostic and treatment centers, training of healthcare workers, and community-level education. These efforts combined can make diagnosis faster, care more accessible and management more effective, bringing the goal of equitable care closer to reality.
Bringing care closer
Hemophilia is a condition where time is often lost before the diagnosis is ever made. For many families, like mine, the journey is marked by years of unanswered questions, repeated hospital visits, and missed signs that, in hindsight, were pointing to a deeper underlying disorder. My brother lived with symptoms from birth, yet it took four decades to receive a diagnosis—time that should have been used to manage, treat, and improve his quality of life. His story is not unique; it reflects a broader systemic gap where diagnosis, especially for rare and chronic conditions, remains fragmented and delayed.
Today, however, there is growing hope in the form of digital health. Work by IntelliSOFT Consulting demonstrates how digital health systems can transform diagnosis through structured, interoperable data. Centralized electronic medical records make it possible to track a patient’s history across multiple facilities, allowing clinicians to identify patterns such as recurrent bleeding episodes that might otherwise go unnoticed. Cross-border and interoperable data-sharing platforms further ensure that critical patient information follows the individual, supporting timely referrals and continuity of care. These tools shift healthcare from isolated encounters to a continuous, data-driven journey—one where early warning signs can be detected sooner and acted upon more effectively.
For conditions like hemophilia, where early diagnosis can mean the difference between life and loss, digital health offers a powerful opportunity to “connect the dots.” It improves visibility of rare conditions, supports structured data collection, and strengthens clinical decision-making. Yet, gaps remain. Many health facilities are still not equipped to recognize or manage hemophilia, and access to diagnostic tools and specialized care is uneven. To truly change outcomes, digital innovation must be paired with investment in capacity, awareness, and equitable access to care. Only then can we ensure that no one else has to wait decades for a diagnosis that could—and should—have come much earlier.
IntelliSOFT’s work at a glance
Hemophilia is often missed due to a fragmented patient history. IntelliSOFT’s work, such as the development of Centralized Electronic Medical Records (EMR) Systems, ensures aggregation of patient data from across facilities into a single unified record. These systems improve patient management and data availability, which are critical for identifying patterns in chronic and rare diseases such as Hemophilia through longitudinal tracking of bleeding episodes, visibility across multiple facilities (ensuring continuity of care for hemophilic patients moving between facilities), and earlier recognition of abnormal bleeding patterns. This also prevents loss of clinical history, supports referral and escalation, and helps clinicians recognize recurring symptoms.
IntelliSOFT’s flagship product, eHospital, integrates registration, consultation, lab orders, and prescriptions into one system. It also ensures end-to-end patient journey visibility using quality data. The system helps clinicians see repeated lab tests, bleeding history and treatment patterns. This system supports systematic, data-driven diagnosis instead of episodic care.
Blood donor management systems are additionally crucial for ensuring the availability of safe blood for transfusion in situations where those affected require blood transfusions. In order to stop the spread of bloodborne diseases, access to safe blood is crucial. These systems involve screening potential donors for bloodborne infections and ensuring that donated blood is properly tested and processed before being used for transfusion. Blood donation programs must be accessible to all individuals, regardless of their gender, race, or socioeconomic status. For hemophilic patients, this access to safe blood is critical.
IntelliSOFT designed, developed and implemented a blood donor management mHealth system with the goal of increasing Kenya’s blood donor pool and encouraging donor retention for subsequent repeat donations. The project aimed to support the government’s policy that every person in Kenya who requires blood has access to safe blood at any time. Later, IntelliSOFT also implemented and trained users of the Blood Safety Information System (BSIS), an electronic information management system developed by Jembi Health Systems as part of a larger Blood Safety Strengthening Programme (BSSP). The work aimed at improving the safety and availability of the blood and blood components available for use in resource-constrained settings in Africa and minimizing the risk to the health of patients receiving blood transfusions.
About the Blood Safety Strengthening Programme (BSSP)
Availability of safe blood for transfusion is a critical aspect of Hemophilia care. This is exactly what the Blood Safety Strengthening Programme aimed to ensure. This multi-country, multi-year programme supported international efforts to improve accessibility and safety of blood in resource-constrained countries by electronically capturing and managing data about blood donors and donations from the point of donation to point of transfusion.